Sanat Chattopadhyay, MSD executive vice-president and president of its manufacturing division, said the expansion was “another new chapter in our long-standing legacy in Ireland”
Carlow was MSD’s first vaccines site outside the US when it was opened in 2008. It now operates as a filling site for both new and existing MSD vaccines, biologics medicines and older generation small molecule drugs. Specialising in providing drug substance for clinical trials and early phase development, it is understood to be the US drug giant’s first such plant outside the US. The latest investment was focused on developing a new research facility next to the biologics manufacturing plant in a move the company says will significantly accelerate the time it takes to bring a medicine to market.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: IrishTimes - 🏆 3. / 98 Read more »